DNA X, Inc. SONM
$3.10
$0.082.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.55M | -14.78M | -20.66M | -33.38M | -31.14M |
| Total Depreciation and Amortization | 2.58M | 3.25M | 4.30M | 3.72M | 3.68M |
| Total Amortization of Deferred Charges | 984.00K | 2.07M | 2.07M | 4.35M | 4.35M |
| Total Other Non-Cash Items | -14.82M | -14.15M | -4.15M | -1.57M | -339.00K |
| Change in Net Operating Assets | 5.30M | 6.22M | -5.09M | 858.00K | 4.03M |
| Cash from Operations | -14.51M | -17.39M | -23.53M | -26.03M | -19.41M |
| Capital Expenditure | -- | -- | -- | -8.00K | -145.00K |
| Sale of Property, Plant, and Equipment | 3.36M | 3.36M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -94.00K | -- | -- | -- | -- |
| Cash from Investing | 3.26M | 3.36M | -- | -8.00K | -145.00K |
| Total Debt Issued | 5.38M | 3.53M | 6.37M | 5.11M | 2.79M |
| Total Debt Repaid | 36.00K | -555.00K | -555.00K | -591.00K | -591.00K |
| Issuance of Common Stock | 4.72M | 10.13M | 13.67M | 14.01M | 9.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.14M | 13.11M | 19.49M | 19.12M | 11.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.11M | -920.00K | -4.04M | -6.92M | -7.59M |